Two-Way Randomized Crossover Study to Establish Pharmacodynamic Bioequivalence Between Oxylanthanum Carbonate and Lanthanum Carbonate

•Large pill burden adversely affects patient compliance with phosphate binders.•Need for complete chewing of phosphate binders may cause variability in efficacy.•Oxylanthanum carbonate is a phosphate binder with small tablets that are swallowed.•Swallowed oxylanthanum carbonate was bioequivalent to...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical therapeutics 2024-11
Hauptverfasser:	Mathur, Vandana, Walker, Michael, Hasal, Steve, Reddy, Guru, Gupta, Shalabh
Format:	Artikel
Sprache:	eng
Schlagworte:	Bioequivalent Chronic kidney disease Hyperphosphatemia Lanthanum Phosphate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!